Insider · CIK 0001579179
Todd C Brady
ceopresidentofficerdirector
Files at ALDX (Aldeyra Therapeutics, Inc.), EVOK (Evoke Pharma Inc). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | EVOK Evoke Pharma Inc | UTender of shares Common Stock | -27 | - | - | 0 | Dec 17, 2025 |
| Dec 17, 2025 | EVOK Evoke Pharma Inc | DDisposition to issuer Stock Option (Right to Buy)derivative | -1,218 | - | - | 0 | Dec 17, 2025 |
| Dec 17, 2025 | EVOK Evoke Pharma Inc | DDisposition to issuer Stock Option (Right to Buy)derivative | -5,833 | - | - | 0 | Dec 17, 2025 |
| Dec 17, 2025 | EVOK Evoke Pharma Inc | DDisposition to issuer Stock Option (Right to Buy)derivative | -1,187 | - | - | 0 | Dec 17, 2025 |
| May 21, 2025 | EVOK Evoke Pharma Inc | AGrant or award Stock Option (Right to Buy)derivative | +1,187 | $0.00 | $0 | 8,238 | May 22, 2025 |
| Mar 4, 2025 | ALDX Aldeyra Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +809,710 | $0.00 | $0 | 809,710 | Mar 6, 2025 |
| Jan 28, 2025 | EVOK Evoke Pharma Inc | AGrant or award Stock Option (Right to Buy)derivative | +5,833 | $0.00 | $0 | 5,833 | Jan 29, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.